Press release
Diabetic Retinopathy Market analysis research and trends report for 2017-2024
Request sample copy @ https://www.gminsights.com/request-sample/detail/486
The National Center for Biotechnology Information (NCBI) estimated that in 2010, 126.6 million people were globally affected by diabetic retinopathy – a figure that is projected to increase to 191 million in 2030. Such an increase in the incidence of diabetic retinopathy will inevitably stimulate the diabetic retinopathy market share, as awareness about the condition is likely to increase the scope of prevention and treatment of this disease. In countries where awareness and treatment facilities are on the lower side, diabetes will continue to prevail, nonetheless, propelling the growth of diabetic retinopathy industry. It is pivotal to remember if left untreated for long, diabetic retinopathy can evolve to become visual threatening diabetic retinopathy (VTDR), which has been identified by the NCBI to be one of the leading causes of blindness around the world. Studies by NCBI attributed 37.3 million cases of blindness due to VTDR, which may increase to 56.3 million in 2030. However, it is prudent to note that an unhealthy lifestyle is not the only cause of this disorder – the patient’s advancing age plays a major role as well to cause diabetic retinopathy or age related macular degeneration (AMD). Thus, diabetic retinopathy market will continue to depict an upward trend between 2017 and 2024 not only because of the increasing cases of diabetes and AMD but also because of rising awareness about diabetic retinopathy and its blindness causing abilities.
Non-proliferative diabetic retinopathy market has been registered to have been dominant in 2016, a trend that is predicted to continue over 2017-2024. Proliferated diabetic retinopathy, on the other hand, is a severe stage of the disorder that can lead to blindness. On that note, it is important to mention that the rising awareness about the disease has indeed prompted diabetic patients to opt for regular eye screenings, which has decreased the incidence of proliferated diabetic retinopathy, negatively impacting diabetic retinopathy industry size.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/486
In case of proliferated diabetic retinopathy, a study suggests that an increased level of vascular endothelial growth factor (VEGF) detected in the fibrovascular tissues of eyes, has led to the usage of anti VEGF, that has proven to be one of the most effective management methods for proliferated diabetic retinopathy, driving the growth of the overall diabetic retinopathy market. Other treatment methods like intraocular steroid injection are also expected to positively influence diabetic retinopathy industry growth, subject to the growing popularity of non-invasive diabetic retinopathy treatment and easy availably of intraocular steroid injections in clinics. However, the results of intraocular steroid injections are less satisfactory than anti VEGF, and therefore will witness limited growth in diabetic retinopathy market.
Diabetes, once deemed as the disease that affected only the affluent, has now reached an epidemic frontier in both developed and developing countries. With the spread of diabetes, related diseases like diabetic retinopathy are also becoming rampant, on the grounds of which diabetic retinopathy industry has been progressing significantly. In North America for instance, U.S. dominated diabetic retinopathy market in 2016, and is projected to continue this trend over 2017-2024, driven by the increased efforts of the American Diabetes Association and other organizations to reign in the spread of diabetes.
Innovation in medical technologies to combat this dreaded disease is expected to positively impact diabetic retinopathy market. With a major upsurge in the prevalence of diabetes and growing elderly population susceptible to lifestyle diseases, it is expected that dynamic research and development in the field of diabetic retinopathy will be reinvigorated, thereby stimulating diabetic retinopathy market size in the ensuing six years.
Report Content
Chapter 1 Methodology & Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data Sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2. Executive Summary
2.1. Diabetic retinopathy industry 3600 synopsis, 2012 - 2024
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Management trends
2.1.4. Regional trends
Chapter 3. Diabetic Retinopathy Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2012 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Growing geriatric population
3.3.1.2. High prevalence of diabetes
3.3.1.3. Increasing occurrence of blindness due to diabetes
3.3.1.4. Large patient population
3.3.2. Industry pitfalls & challenges
3.3.2.1. Dearth of trained ophthalmologists
3.3.2.2. Extensive time for approval of drugs
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By management
3.5. Porter’s analysis
3.6. Competitive landscape, 2016
3.6.1. Strategy dashboard
3.7. PESTEL analysis
3.8. Diabetic retinopathy epidemiology
3.8.1. U.S.
3.8.2. Germany
3.8.3. UK
3.8.4. China
3.9. Diabetic retinopathy pipeline
Chapter 4. Diabetic Retinopathy Market, By Type
4.1. Global diabetic retinopathy market share, by type, 2016 & 2024
4.2. Proliferative
4.2.1. Market estimates and forecast, by region, 2012 - 2024
4.3. Non-Proliferative
4.3.1. Market estimates and forecast, by region, 2012 - 2024
Chapter 5. Diabetic Retinopathy Market, By Management
5.1. Global diabetic retinopathy market share, by management, 2016 & 2024
5.2. Anti-VEGF therapy
5.2.1. Market estimates and forecast, by region, 2012 - 2024
5.3. Intraocular steroid injection
5.3.1. Market estimates and forecast, by region, 2012 - 2024
5.4. Laser surgery
5.4.1. Market estimates and forecast, by region, 2012 - 2024
5.5. Vitrectomy
5.5.1. Market estimates and forecast, by region, 2012 - 2024
Chapter 6. Diabetic Retinopathy Market, By Region
6.1. Diabetic retinopathy market share, by region, 2016 & 2024
6.2. North America
6.2.1. Market estimates and forecast, by country, 2012 - 2024
6.2.2. Market estimates and forecast, by type, 2012 - 2024
6.2.3. Market estimates and forecast, by management, 2012 - 2024
6.2.4. U.S.
6.2.4.1. Market estimates and forecast, by type, 2012 - 2024
6.2.4.2. Market estimates and forecast, by management, 2012 - 2024
6.2.5. Canada
6.2.5.1. Market estimates and forecast, by type, 2012 - 2024
6.2.5.2. Market estimates and forecast, by management, 2012 - 2024
6.3. Europe
6.3.1. Market estimates and forecast, by country, 2012 - 2024
6.3.2. Market estimates and forecast, by type, 2012 - 2024
6.3.3. Market estimates and forecast, by management, 2012 - 2024
6.3.4. Germany
6.3.4.1. Market estimates and forecast, by type, 2012 - 2024
6.3.4.2. Market estimates and forecast, by management, 2012 - 2024
6.3.5. UK
6.3.5.1. Market estimates and forecast, by type, 2012 - 2024
6.3.5.2. Market estimates and forecast, by management, 2012 - 2024
6.4. Asia Pacific
6.4.1. Market estimates and forecast, by country, 2012 - 2024
6.4.2. Market estimates and forecast, by type, 2012 - 2024
6.4.3. Market estimates and forecast, by management, 2012 - 2024
6.4.4. Japan
6.4.4.1. Market estimates and forecast, by type, 2012 - 2024
6.4.4.2. Market estimates and forecast, by management, 2012 - 2024
6.4.5. China
6.4.5.1. Market estimates and forecast, by type, 2012 - 2024
6.4.5.2. Market estimates and forecast, by management, 2012 - 2024
6.5. Latin America
6.5.1. Market estimates and forecast, by country, 2012 - 2024
6.5.2. Market estimates and forecast, by type, 2012 - 2024
6.5.3. Market estimates and forecast, by management, 2012 - 2024
6.5.4. Brazil
6.5.4.1. Market estimates and forecast, by type, 2012 - 2024
6.5.4.2. Market estimates and forecast, by management, 2012 - 2024
6.6. Middle East & Africa
6.6.1. Market estimates and forecast, by country, 2012 - 2024
6.6.2. Market estimates and forecast, by type, 2012 - 2024
6.6.3. Market estimates and forecast, by management, 2012 - 2024
6.6.4. South Africa
6.6.4.1. Market estimates and forecast, by type, 2012 - 2024
6.6.4.2. Market estimates and forecast, by management, 2012 - 2024
Chapter 7. Company Profiles
7.1. Aerpio Pharmaceuticals
7.1.1. Business overview
7.1.2. Financial data
7.1.3. Product landscape
7.1.4. Strategic outlook
7.1.5. SWOT analysis
7.2. Alimera Sciences, Inc
7.2.1. Business overview
7.2.2. Financial data
7.2.3. Product landscape
7.2.4. Strategic outlook
7.2.5. SWOT analysis
7.3. Allergan PLC (Actavis PLC)
7.3.1. Business overview
7.3.2. Financial data
7.3.3. Product landscape
7.3.4. Strategic outlook
7.3.5. SWOT analysis
7.4. Ampio Pharmaceuticals, Inc.
7.4.1. Business overview
7.4.2. Financial data
7.4.3. Product landscape
7.4.4. Strategic outlook
7.4.5. SWOT analysis
7.5. Bayer AG
7.5.1. Business overview
7.5.2. Financial data
7.5.3. Product landscape
7.5.4. Strategic outlook
7.5.5. SWOT analysis
7.6. BCN Peptides S.A.
7.6.1. Business overview
7.6.2. Financial data
7.6.3. Product landscape
7.6.4. Strategic outlook
7.6.5. SWOT analysis
7.7. Genentech, Inc.
7.7.1. Business overview
7.7.2. Financial data
7.7.3. Product landscape
7.7.4. Strategic outlook
7.7.5. SWOT analysis
7.8. Kowa Company Ltd.
7.8.1. Business overview
7.8.2. Financial data
7.8.3. Product landscape
7.8.4. Strategic outlook
7.8.5. SWOT analysis
7.9. Novartis AG
7.9.1. Business overview
7.9.2. Financial data
7.9.3. Product landscape
7.9.4. Strategic outlook
7.9.5. SWOT analysis
7.10. Regeneron Pharmaceuticals, Inc.
7.10.1. Business overview
7.10.2. Financial data
7.10.3. Product landscape
7.10.4. Strategic outlook
7.10.5. SWOT analysis
7.11. Sirnaomics, Inc.
7.11.1. Business overview
7.11.2. Financial data
7.11.3. Product landscape
7.11.4. Strategic outlook
7.11.5. SWOT analysis
7.12. ThromboGenics
7.12.1. Business overview
7.12.2. Financial data
7.12.3. Product landscape
7.12.4. Strategic outlook
7.12.5. SWOT analysis
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Retinopathy Market analysis research and trends report for 2017-2024 here
News-ID: 984772 • Views: …
More Releases from Global Market Insights, Inc.
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health.
This in turn has led to a surge in demand for various functional foods…
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock.
According to Global Market Insights Inc estimates…
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091
Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group…
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products.
Prenatal vitamin ingredients can…
More Releases for Business
Business Consulting Company, Business Consulting Firm, Business Consulting Servi …
The market research is an essential portion of any business strategy and primarily comprises of the data collecting about the markets and consumers in those markets. In recent’s globalized business surroundings, effective market research is a critical portion of any business’s efforts to compete successfully.
At Ken Research, the market research services support businesses identify growth opportunities and form a competitive strategy reliant on the deep understanding of consumers and…
Business to Business Media Market 2019 Business Scenario – Bloomberg, IBM, Ora …
A new Profession Intelligence Report released by Stats and Reports with the title Global Business to Business Media Market "can grow into the most important market in the world that has played an important role in making progressive impacts on the global economy. Global Business to Business Media Market Report presents a dynamic vision to conclude and research market size, market hope and competitive environment. The study is derived from…
Business to Business (B2B) Telecommunication Market Prolific Business Methodolog …
B2B telecommunications is a form of communications that takes place between companies in different forms such as text, voice, video, emails, and among others. B2B telecommunication providers maintain systems that transmit data, text, sound, and voice and video, which facilitates direct communication between businesses. Telecommunications platforms can also be utilized by marketers in order to boost a company's visibility within the industry and identify networking opportunities.
Request For Customization of Research…
Business Alliance Market Growing Dynamically with Leading Top Key Players like B …
A business alliance is an agreement between businesses, usually motivated by cost reduction and improved service for the customer. Alliances are often bounded by a single agreement with equitable risk and opportunity share for all parties involved and are typically managed by an integrated project team. An example of this is code sharing in airline alliances.
The Global Business Alliance Market 2019 research provides a basic overview of the industry including…
Global Interferon Market Business Growth, Business Opportunities, Business Outlo …
Albany, NY, USA / 16 Oct 2018: - A New fresh research report presented by KD Market Insights provides a detailed analysis of “Global Interferon Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business…
Global Intramuscular Immune Globulin Market Business Growth, Business Opportunit …
Albany, NY, USA / 16 Oct 2018: - A New fresh research report presented by KD Market Insights provides a detailed analysis of “Global Intramuscular Immune Globulin Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges…
